India’s BDR Files Compulsory License For BMS’ Sprycel; Next Up Ixempra And Herceptin?

 
• By Vikas Dandekar
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia